フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Shire Settles All Pending Litigation with Actavis and Watson Concerning INTUNIV® PR Newswire PHILADELPHIA, April 25, 2013 PHILADELPHIA, April 25...
BRAVE Awards Now Accepting Nominations International awards program honors non-professional caregivers PR Newswire DUBLIN, Ireland, April 24...
BRAVE Awards Now Accepting Nominations PR Newswire DUBLIN, Ireland, April 24, 2013 DUBLIN, Ireland, April 24, 2013 /PRNewswire/ -- International...
Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology Acquisition brings Shire a new phase 3 compound being investigated for the...
Shire Acquires Premacure AB Deal Enhances Shire's Late-Stage Pipeline with the Acquisition of a Phase II Protein Replacement Therapy Being...
Shire Supports Rare Disease Day 2013 PR Newswire LEXINGTON, Massachusetts, February 28, 2013 LEXINGTON, Massachusetts, February 28, 2013...
Shire's VPRIV® Wins First Ever "Novel Treatment Award" From Lysosomal Disease Network at Their 9th WORLD Symposium PR...
Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013 PR Newswire DUBLIN, Ireland, February 14, 2013 DUBLIN, Ireland, February 14...
Shire and Impax Settle Litigation Concerning Supply of Adderall XR Authorized Generic Shire and Impax Settle Litigation Concerning Supply of...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約